Early skin cancer detection via telemedicine in primary care
Part of Cancer, Skin clinical trials.
This study tests if a telemedicine tool can help find skin tumors early. It may be a good fit if you have a suspicious spot and light skin that burns easily.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have at least one skin spot that your doctor thinks might be suspicious.
- Your skin type is very fair (light skin that always burns, never tans).
- You haven't seen a skin doctor (dermatologist) in the past year.
- You are willing to sign a consent form to join the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an artificial intelligence (AI) system that helps doctors decide if a skin lesion might be cancer. If you are seeing your primary care doctor about a mole or spot that concerns them or you, this study might be for you.
This study tests a way for doctors to send clear images of your skin spot to be reviewed remotely using teledermoscopy (digital images of the skin). It may help speed up specialist input and improve how skin spots are assessed.
This trial tests an artificial-intelligence smartphone app that helps spot possible skin cancer by looking at skin spots (lesions). You may benefit by getting guidance on whether your new or changing mole needs closer attention.
This study looks at diagnostic and prognostic factors in people who have suspicious pigmented skin lesions or melanoma that doctors are evaluating with surgery or tissue sampling. It may help improve how clinicians decide what the lesion is and what to expect over time.
This trial tests a new educational program to help people learn how to check their own skin for signs of skin cancer. It aims to make early detection easier, and you can join regardless of whether you have had skin cancer before.
This trial is testing a special light-based technique (Raman spectroscopy) to see if it can help doctors better identify skin cancers. It is for people with either basal cell or squamous cell carcinoma who are scheduled to receive brachytherapy treatment.
Hear when a new Skin Cancer Prevention trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.